AI Insight
Researchers developed a microfluidic device called the Cytotongue system that can detect mechanical changes in tumor spheroids during CAR-T cell therapy without using labels or dyes. The system measures how tumor cells become mechanically softer when attacked by CAR-T cells, enabling detection of therapeutic response within hours rather than days. This mechanical softening occurs before other visible signs of cell death and correlates with the effectiveness of the CAR-T treatment.
Why it matters
This technology could enable much faster assessment of whether CAR-T cell therapy is working in individual patients, potentially allowing doctors to adjust treatment protocols within hours instead of waiting days or weeks for conventional biomarkers. The label-free approach also means it could be used for real-time monitoring without disrupting the cells or requiring additional chemical markers.
Understand the Science